We&Win Diversification Co Ltd (4113) - Cash Flow Conversion Efficiency
Based on the latest financial reports, We&Win Diversification Co Ltd (4113) has a cash flow conversion efficiency ratio of -0.006x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-24.89 Million ≈ $-784.14K USD) by net assets (NT$4.18 Billion ≈ $131.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of We&Win Diversification Co Ltd for the company's overall valuation and market capitalisation.
We&Win Diversification Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how We&Win Diversification Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
We&Win Diversification Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of We&Win Diversification Co Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of We&Win Diversification Co Ltd to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cnergenz Bhd
KLSE:0246
|
0.031x |
|
Iris Clothings Limited
NSE:IRISDOREME
|
-0.103x |
|
Phoenix Tours International Inc
TW:5706
|
-0.001x |
|
Min Aik Technology Co Ltd
TW:3060
|
-0.028x |
|
Vakif Finansal Kiralama AS
IS:VAKFN
|
-0.258x |
|
AMREP Corporation
NYSE:AXR
|
0.025x |
|
Soquicom
SN:SOQUICOM
|
-0.106x |
|
Innate Pharma
PA:IPH
|
0.995x |
Annual Cash Flow Conversion Efficiency for We&Win Diversification Co Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of We&Win Diversification Co Ltd from 2017 to 2025. View latest We&Win Diversification Co Ltd stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$4.27 Billion ≈ $134.43 Million |
NT$-2.92 Billion ≈ $-91.95 Million |
-0.684x | -239.56% |
| 2024-12-31 | NT$4.52 Billion ≈ $142.55 Million |
NT$2.22 Billion ≈ $69.87 Million |
0.490x | +262.79% |
| 2023-12-31 | NT$3.11 Billion ≈ $98.08 Million |
NT$-937.22 Million ≈ $-29.53 Million |
-0.301x | +34.45% |
| 2022-12-31 | NT$3.26 Billion ≈ $102.67 Million |
NT$-1.50 Billion ≈ $-47.16 Million |
-0.459x | -1233.09% |
| 2021-12-31 | NT$3.49 Billion ≈ $109.87 Million |
NT$141.35 Million ≈ $4.45 Million |
0.041x | +107.33% |
| 2020-12-31 | NT$3.42 Billion ≈ $107.65 Million |
NT$-1.89 Billion ≈ $-59.55 Million |
-0.553x | -473.46% |
| 2019-12-31 | NT$3.52 Billion ≈ $110.99 Million |
NT$521.83 Million ≈ $16.44 Million |
0.148x | +280.99% |
| 2018-12-31 | NT$3.73 Billion ≈ $117.54 Million |
NT$145.05 Million ≈ $4.57 Million |
0.039x | +135.02% |
| 2017-12-31 | NT$3.61 Billion ≈ $113.60 Million |
NT$-400.30 Million ≈ $-12.61 Million |
-0.111x | -- |
About We&Win Diversification Co Ltd
We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public facilities construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 20… Read more